Company: BLLN
Filing Date: 2025-12-10
Form Type: 10-Q
Source: 0001628280-25-056321
Chunk: 340

Company: BillionToOne, Inc.
Filing Date: 2025-12-10
Form: 10-Q
Item: Part II, Item 3
Chunk 340
---
Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

None.

Item 5. Other Information

Disclosure of Trading Arrangements

During the fiscal quarter ended September 30, 2025, none of our directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K. 

Item 6. Exhibits 

(a) Exhibits

Exhibit NoDescription of ExhibitFormFile No.Exhibit NumberFiling DateFiled or Furnished Herewith3.1Amended and Restated Certificate of Incorporation of the Registrant8-K001-429343.1November 10, 20253.2Amended and Restated Bylaws of Registrant8-K001-429343.2November 10, 202510.1Amendment No. 1 to the Note Purchase Agreement, dated as September 4, 2025, by and among by and among the Registrant, the purchasers party thereto, and BWCB SA LLC (an entity affiliated with Oberland Capital Management, LLC), as purchaser’s agent.S-1333-29076110.2October 07, 202510.2Development and Commercialization Agreement with Janssen Biotech, Inc., dated July 11, 2025S-1/A333-29076110.10October 17, 202510.3Amendment No. 1 to Development and Commercialization Agreement with Janssen Biotech, Inc., dated October 15, 2025S-1/A333-29076110.11October 17, 202510.4+Form of Indemnification Agreement by and between the Registrant and each of its directors and executive officersS-1333-29076110.11October 07, 202510.5+2025 Equity Incentive PlanS-1/A333-29076110.14October 17, 202510.6+2025 Employee Stock Purchase PlanS-1/A333-29076110.15October 17, 202510.7+Executive Severance PlanS-1/A333-29076110.16October 17, 202531.1Certification of Chief Executive Officer pursuant to Section 302